← All Signals

🏥 FDA: Pro Numb Tattoo Numbing Spray LLC — Class II

healthcarebearishSource: FDA
75%Confidence
0Views
FDASource
2026-03-05Date

Summary

Pro Numb Tattoo Numbing Spray faces cGMP deviations, indicating manufacturing quality issues in the growing topical anesthetic market. This could create opportunities for competitors with stronger regulatory compliance.

Actionable: Look for investment opportunities in competing numbing product manufacturers with clean regulatory records.

AI Confidence: 75%

Data Points

firmPro Numb Tattoo Numbing Spray LLC
classificationClass II
statusOngoing
distributionNationwide in the USA
productPro Numb Tattoo Numbing Spray, 5% Lidocaine, [1 FL OZ/28.4 ML or 4 oz/120 mL] per bottle, Distributed by: Pro Numb Tattoo numbing spray LLC, Melbourne

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now